Home
Dashboard
Curated content
Startups & Scaleups
SMEs & Corporates
Investors
Funding rounds
Accelerators
Universities
Governments & Non-profits
More organizations
Matching tool
Companies
Obsidian Therapeutics
Team
Team
Save
Obsidian Therapeutics
Aspires to extend adoptive immunotherapy.
Launch date
2015
Employees
51-200 people
Market cap
-
Enterprise valuation
€584—875m
(Dealroom.co estimates Apr 2024.)
Cambridge Massachusetts (HQ)
http://obsidiantx.com/
https://twitter.com/obsidian_tx
https://www.linkedin.com/company/obsidian-therapeutics
View job openings
B2B
B2C
health
biotechnology
hard tech
biotechnology
biotech and pharma
synthetic biology
immune system
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Patents (31)
Authorizing premium user...